02/14/2011 - 1:06pm

New research published in the Feb. 14 online edition of Pediatrics found that prolonged use of energy drinks by young people can lead to potentially adverse health outcomes.

02/14/2011 - 11:52am

An increase in consolidation among generic drug companies could be in the works, according to a new report from Thomson Reuters.

02/11/2011 - 4:10pm

It never made much sense to make health care less affordable under the Affordable Care Act — neither did the requirement of a prescription for a nonprescription remedy jive with proponents of flexible spending accounts. So it’s little wonder that the FSA rule changes were the first piece of ObamaCare to face a congressional axe, as was widely speculated just last week.

02/11/2011 - 3:53pm

"Try the brand of health-and-wellness products our pharmacists recommend," reads a new ad from Walgreens that hit Sunday papers this past weekend, extolling the virtues of the Walgreens store brand. This should serve as a wake-up call to the vendor community — particularly, over-the-counter manufacturers — that retailers are putting a greater emphasis on private label than ever before. Walgreens clearly is investing big dollars with this campaign to promote it like a national brand, to send a message to consumers that its brand is "quality [they] can trust."

02/11/2011 - 3:32pm

It stands to reason that as the first line of health care in the community, retail pharmacy can place itself at the forefront of efforts to promote prevention of disease.

02/11/2011 - 1:59pm

Genentech, a subsidiary of Roche, reported that its eye drug helped improve vision in patients suffering from a complication caused by diabetes.

02/11/2011 - 12:04pm

A multicultural study that will appear in the March issue of the Journal of Renal Care underscored the relationship between kidney disease and diabetes, and the need for greater awareness of this link.

02/10/2011 - 1:39pm

Hispanics will wield $1.2 trillion in buying power in less than a year, the SymphonyIRI Group and partner Synovate noted Wednesday in a new joint market research report.

02/09/2011 - 2:27pm

Women with ovarian cancer who received a drug made by Genentech lived longer without their disease becoming worse, according to a late-stage clinical trial.